Why the study?
Heart failure and ventricular remodeling after acute myocardial infarction adversely affect prognosis, prompting investigation into whether death-associated protein kinase 1 (DAPK1) represents a therapeutic target.
Does DAPK1 inhibition reduce myocardial injury, inflammation, and oxidative stress in a rat model of acute myocardial infarction?
Does DAPK1 inhibition reduce myocardial injury, inflammation, and oxidative stress in a rat model of acute myocardial infarction?
DAPK1 inhibition protects cardiomyocytes from AMI-induced injury by reducing inflammation and oxidative stress in a preclinical rat model.
Answers are grounded in this paper and cite their sources.
May identify DAPK1 as AMI target in rats; leaves open translation to human therapy.
OBJECTIVE: Heart failure and ventricular remodeling after acute myocardial infarction (AMI) are important factors affecting the prognosis of patients. Therefore, we expected to explore the therapeutic target of AMI by studying the effect of death-associated protein kinase 1 (DAPK1) on AMI rat model. MATERIALS AND METHODS: We used male Sprague-Dawley rats to make AMI model, and after 1, 3, 7, and 14 d, we detect the success rate of modeling and the expression change of DAPK1 through 2, 3, 5-triphenyl tetrazolium chloride staining, myocardial injury markers detection, echocardiographic detection, and histological experiment. In addition, we determined the effect of DAPK1 on AMI by subcutaneous injection of the DAPK1 inhibitor (TC-DAPK 6). The effect of DAPK1 on cardiomyocytes has also been verified in cell experiments on H9c2 cells. RESULTS: ) in AMI rats treated by TC-DAPK 6 was reduced. In addition, TC-DAPK 6 also reduced the activity of malonaldehyde and increased the activities of superoxide dismutase, glutathione, and catalase. The expression of antioxidant molecules such as peroxiredoxin1/4 and glutathione peroxidase1/3 was also promoted by TC-DAPK 6. In H9c2 cells, TC-DAPK 6 also reduced its oxidative stress level. CONCLUSIONS: The increase of DAPK1 may be related to the pathogenesis of AMI. DAPK1 inhibitors protect cardiomyocytes from AMI-induced myocardial injury by reducing levels of inflammation and oxidative stress in myocardial tissue and cells.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: